Second-generation prophylactic HPV vaccines: successes and challenges. - Wikidata - wikimedia - TriplyDB

Second-generation prophylactic HPV vaccines: successes and challenges.

Second-generation prophylactic HPV vaccines: successes and challenges.

http://www.wikidata.org/entity/Q35541886

about

Health Disparities in the Immunoprevention of Human Papillomavirus Infection and Associated Malignancies Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse models Plant-based vaccines against viruses.Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2 Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.Invasive cervical cancers in the United States, Botswana and Kenya: HPV type distribution and health policy implications.Recent progress in vaccination against human papillomavirus-mediated cervical cancer.Trop2 gene: a novel target for cervical cancer treatment.A plant protein signal sequence improved humoral immune response to HPV prophylactic and therapeutic DNA vaccines.Virus like particles as a platform for cancer vaccine development.

P2860

Q26770541-4E38E3C9-4517-4E1B-BB2E-330F831128BF Q28083154-EC409414-F5FD-47F2-AF5A-08E9B897140F Q34687464-22C5EC9C-05E3-4782-BE7D-FBBD2F9EC2B5 Q35744303-76EFF47B-4775-4B12-881E-F60F2F1262D2 Q37073299-256B38CF-D940-415F-A3D5-FD3389CA48CF Q37408880-35C1FD1B-9710-4406-8686-8E1B66500FC2 Q38370782-D98DA7E7-77E5-4BB7-907E-0AC17F140693 Q38996163-AE4B54ED-E519-4BE8-AB32-A5539CF96645 Q40360089-C51B965C-7A26-4CDC-BB8F-F7480C9A10A4 Q45324534-660D74BC-B0D9-4F6F-8CE4-F4432BA877C9

P2860

Second-generation prophylactic HPV vaccines: successes and challenges.

http://www.wikidata.org/entity/Q35541886

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Second-generation prophylactic HPV vaccines: successes and challenges.

@ast

Second-generation prophylactic HPV vaccines: successes and challenges.

@en

type

label

Second-generation prophylactic HPV vaccines: successes and challenges.

@ast

Second-generation prophylactic HPV vaccines: successes and challenges.

@en

prefLabel

Second-generation prophylactic HPV vaccines: successes and challenges.

@ast

Second-generation prophylactic HPV vaccines: successes and challenges.

@en

P1433

Q35541886-8E4D3C19-61D0-4E17-99B4-DDBB5FE2327A

P1476

Q35541886-722778E3-4846-4C2A-AEF6-CD5B349ADA8B

P2093

Q35541886-0E9AF1B4-BF17-444C-BAF8-027AED693440

Q35541886-34FD6D1E-C1A5-4837-95A8-87B9A83D4A90

Q35541886-D7EF664B-E69E-4AD2-8C00-E24DE4BC4046

P2860

Q35541886-02AF5F4A-06CF-4C82-8E74-082FABF0EB03

Q35541886-02E843BC-39BB-487E-B62D-C84CB39BFAE0

Q35541886-0C160013-A3D3-4C03-AE1D-35E3C13317AA

Q35541886-0EAEDB66-918B-408F-B678-FC4748B7C745

Q35541886-0FC78CD6-12CE-4845-9C6D-3C09F12C0F35

Q35541886-113A199E-05D9-4F44-80E5-EF04780A1BF5

Q35541886-1A01D930-C9F4-482D-990B-70AE6EF0C7F7

Q35541886-1FEE8744-E629-43EF-B523-DCDA9A62144B

Q35541886-202292A4-A6D2-42D2-9F14-FAB1BF1A6F2A

Q35541886-263E7599-7EF4-4FC5-B164-7B56F781EE41

P304

Q35541886-61D7FE3C-DF97-4FDC-9DED-C41731AA0BEF

P31

Q35541886-C5ECE8A7-F882-4145-98B6-6E5D813854C9

P356

Q35541886-1CBC4B55-364A-44D9-90F5-830215F7ADC0

P433

Q35541886-B446E491-8DCB-404D-A42F-DB49FAFC475E

P478

Q35541886-69491A83-290B-4E54-97B9-F1C81541B269

P577

Q35541886-6F1FB3E8-76E9-489C-8E52-5ABBBB2A4303

P698

Q35541886-17A56464-FC78-468B-B099-E8051E3A5810

P932

Q35541886-3EFD8E1C-58BA-4678-8F74-E274CEABD171

P356

14760584.2014.865523

P1433

Expert Review of Vaccines

P1476

Second-generation prophylactic HPV vaccines: successes and challenges.

@en

P2093

Bryce Chackerian

http://www.w3.org/2001/XMLSchema#string

Ebenezer Tumban

http://www.w3.org/2001/XMLSchema#string

Mitchell Tyler

http://www.w3.org/2001/XMLSchema#string

P2860

Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes

Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate

Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years

VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia

Case-control study of human papillomavirus and oropharyngeal cancer

P304

247-255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14760584.2014.865523

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24350614

http://www.w3.org/2001/XMLSchema#string

P932

4410880

http://www.w3.org/2001/XMLSchema#string